Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Read More…
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Phone201-329-7300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$828 million
Profitability
Miscellaneous
Employees1,600
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable
Phibro Animal Health (NASDAQ:PAHC) Frequently Asked Questions
What is Phibro Animal Health's stock symbol?
Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."
How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?
Phibro Animal Health announced a quarterly dividend on Monday, July 29th. Shareholders of record on Wednesday, September 4th will be given a dividend of $0.12 per share on Wednesday, September 25th. This represents a $0.48 dividend on an annualized basis and a yield of 2.15%. The ex-dividend date of this dividend is Tuesday, September 3rd. View Phibro Animal Health's Dividend History.
How were Phibro Animal Health's earnings last quarter?
Phibro Animal Health Corp (NASDAQ:PAHC) issued its quarterly earnings data on Tuesday, August, 27th. The company reported $0.33 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.34 by $0.01. The business earned $203.90 million during the quarter, compared to analyst estimates of $206 million. Phibro Animal Health had a return on equity of 29.99% and a net margin of 6.59%. The firm's quarterly revenue was down 3.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.46 EPS. View Phibro Animal Health's Earnings History.
When is Phibro Animal Health's next earnings date?
What guidance has Phibro Animal Health issued on next quarter's earnings?
Phibro Animal Health updated its FY20 earnings guidance on Tuesday, August, 27th. The company provided EPS guidance of $1.08 -1.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.66. The company issued revenue guidance of $833 -863 million, compared to the consensus revenue estimate of $857.96 million.
What price target have analysts set for PAHC?
5 brokerages have issued 1-year target prices for Phibro Animal Health's shares. Their forecasts range from $18.00 to $42.00. On average, they anticipate Phibro Animal Health's share price to reach $26.60 in the next twelve months. This suggests a possible upside of 19.2% from the stock's current price. View Analyst Price Targets for Phibro Animal Health.
What is the consensus analysts' recommendation for Phibro Animal Health?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 2 sell ratings, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Phibro Animal Health.
Has Phibro Animal Health been receiving favorable news coverage?
News articles about PAHC stock have trended negative recently, according to InfoTrie. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Phibro Animal Health earned a coverage optimism score of -2.9 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Phibro Animal Health.
Are investors shorting Phibro Animal Health?
Phibro Animal Health saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 839,000 shares, an increase of 5.3% from the July 31st total of 796,900 shares. Based on an average daily trading volume, of 153,700 shares, the days-to-cover ratio is presently 5.5 days. Currently, 4.2% of the company's stock are short sold. View Phibro Animal Health's Current Options Chain.
Who are some of Phibro Animal Health's key competitors?
Some companies that are related to Phibro Animal Health include FibroGen (FGEN), Alkermes (ALKS), Mirati Therapeutics (MRTX), Evotec (EVTCY), Taro Pharmaceutical Industries (TARO), Global Blood Therapeutics (GBT), BridgeBio Pharma (BBIO), Arrowhead Pharmaceuticals (ARWR), HUTCHISON CHINA/S (HCM), Emergent Biosolutions (EBS), Reata Pharmaceuticals (RETA), Genmab A/S (GMAB), Arena Pharmaceuticals (ARNA), Ultragenyx Pharmaceutical (RARE) and PTC Therapeutics (PTCT).
What other stocks do shareholders of Phibro Animal Health own?
Who are Phibro Animal Health's key executives?
Phibro Animal Health's management team includes the folowing people:
- Mr. Jack Clifford Bendheim, Chairman, Pres & CEO (Age 72)
- Mr. Larry L. Miller, Chief Operating Officer (Age 55)
- Mr. Dean J. Warras, Pres of Animal Health & Nutrition - North America (Age 50)
- Mr. Richard G. Johnson, Chief Financial Officer (Age 70)
- Mr. Thomas G. Dagger, Sr. VP, Gen. Counsel & Corp. Sec. (Age 61)
Who are Phibro Animal Health's major shareholders?
Phibro Animal Health's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.04%), Vanguard Group Inc. (5.58%), Fiduciary Management Inc. WI (2.65%), Janus Henderson Group PLC (2.37%), Janus Henderson Group PLC (2.37%) and Renaissance Technologies LLC (1.87%). Company insiders that own Phibro Animal Health stock include Bfi Co, Llc, Daniel M Bendheim, Dean J Warras, E Thomas Corcoran, Jack Bendheim and Larry Lee Miller. View Institutional Ownership Trends for Phibro Animal Health.
Which major investors are selling Phibro Animal Health stock?
PAHC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, D. E. Shaw & Co. Inc., Prudential Financial Inc., Wells Fargo & Company MN, Citadel Advisors LLC, AQR Capital Management LLC and Invesco Ltd.. Company insiders that have sold Phibro Animal Health company stock in the last year include Daniel M Bendheim and Dean J Warras. View Insider Buying and Selling for Phibro Animal Health.
Which major investors are buying Phibro Animal Health stock?
PAHC stock was purchased by a variety of institutional investors in the last quarter, including Fiduciary Management Inc. WI, Janus Henderson Group PLC, Janus Henderson Group PLC, Nuveen Asset Management LLC, Chartwell Investment Partners LLC, Marshall Wace LLP, Vanguard Group Inc. and Tocqueville Asset Management L.P.. View Insider Buying and Selling for Phibro Animal Health.
How do I buy shares of Phibro Animal Health?
Shares of PAHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Phibro Animal Health's stock price today?
One share of PAHC stock can currently be purchased for approximately $22.32.
How big of a company is Phibro Animal Health?
Phibro Animal Health has a market capitalization of $902.91 million and generates $828 million in revenue each year. The company earns $54.71 million in net income (profit) each year or $1.53 on an earnings per share basis. Phibro Animal Health employs 1,600 workers across the globe.View Additional Information About Phibro Animal Health.
What is Phibro Animal Health's official website?
How can I contact Phibro Animal Health?
Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The company can be reached via phone at 201-329-7300 or via email at [email protected]
MarketBeat Community Rating for Phibro Animal Health (NASDAQ PAHC)
MarketBeat's community ratings are surveys of what our community members think about Phibro Animal Health and other stocks. Vote "Outperform" if you believe PAHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PAHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
